Search for other works by this author on: ...
Department of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
1Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
Cancer Res (2025) 85 (8_Supplement_1): 6376.
Abstract. T-cell engagers (TCEs) display increasing potential as an immunotherapeutic treatment for both hematologic and solid cancers. These multi-specific antibody-based therapeutics consist of a ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
1Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio. 2Case Comprehensive Cancer Center, Cleveland, Ohio.
1Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum – MKFZ, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany.
1Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. 2Navarra Institute for Health Research (IDISNA), Pamplona, Spain. 3Centro de Investigación Biomédica en Red de ...
Cancer Res (2024) 84 (7_Supplement): LB271.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback